Evolution Wealth Management’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
Other funds holding ARQT
Evolution Wealth Management's ARQT Position: Q3 2026 in Review
Evolution Wealth Management opened a new position in Arcutis Biotherapeutics (ARQT) in Q3 2026: 491 shares worth $13K. The stake represents 0.01% of the portfolio and ranks #488 among its holdings.
294 funds tracked by Wall St. Rank hold ARQT as of Q3 2026.
- Evolution Wealth Management held 491 shares of Arcutis Biotherapeutics worth $13K as of Q3 2026.
- Arcutis Biotherapeutics was a new Evolution Wealth Management position in Q3 2026.
- Arcutis Biotherapeutics made up 0.01% of Evolution Wealth Management's portfolio in Q3 2026, its #488 holding.
- 294 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q3 2026.
Based on Evolution Wealth Management's 13F filing for Q3 2026, filed 28 Oct 2026.